RadNet (RDNT) Valuation Check After Short-Seller Critique and Raymond James’ Defense of Its AI Story

Simply Wall St.12-20

RadNet (RDNT) has been on a rollercoaster after Hunterbrook Capital’s short report hammered the stock, only for Raymond James to step in and defend the company, remaining positive on its long term ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592373111?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","is_english":true,"pubTime":"2025-12-20 10:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592373111","market":"sg","top_or_hot":-1,"title":"RadNet (RDNT) Valuation Check After Short-Seller Critique and Raymond James’ Defense of Its AI Story","media":"Simply Wall St.","content":"<div>\n<p>RadNet (RDNT) has been on a rollercoaster after Hunterbrook Capital’s short report hammered the stock, only for Raymond James to step in and defend the company, remaining positive on its long term ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-rdnt/radnet/news/radnet-rdnt-valuation-check-after-short-seller-critique-and\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RadNet (RDNT) Valuation Check After Short-Seller Critique and Raymond James’ Defense of Its AI Story</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRadNet (RDNT) Valuation Check After Short-Seller Critique and Raymond James’ Defense of Its AI Story\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-20 10:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-rdnt/radnet/news/radnet-rdnt-valuation-check-after-short-seller-critique-and><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>RadNet (RDNT) has been on a rollercoaster after Hunterbrook Capital’s short report hammered the stock, only for Raymond James to step in and defend the company, remaining positive on its long term ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-rdnt/radnet/news/radnet-rdnt-valuation-check-after-short-seller-critique-and\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-rdnt/radnet/news/radnet-rdnt-valuation-check-after-short-seller-critique-and","article_id":"2592373111","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-rdnt/radnet/news/radnet-rdnt-valuation-check-after-short-seller-critique-and","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2592373111","pubTimestamp":1766197093,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"RadNet (RDNT) has been on a rollercoaster after Hunterbrook Capital’s short report hammered the stock, only for Raymond James to step in and defend the company, remaining positive on its long term outlook.\nSee our latest analysis for RadNet.\nAgainst that backdrop, RadNet’s share price has whipsawed but is still up solidly on a year to date basis. Its exceptional three year total shareholder return suggests the long term momentum story is intact despite near term volatility.\nIf this kind of...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","BK4023":"应用软件","LU0971096721.USD":"富达环球金融服务 A","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","BK4543":"AI","AI":"C3.ai, Inc.","BK4585":"ETF&股票定投概念","BK4127":"投资银行业与经纪业","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","BK4587":"ChatGPT概念","BK4528":"SaaS概念","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC","RJF":"瑞杰金融","BK4588":"碎股","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","RDNT":"RadNet","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","BK4551":"寇图资本持仓"},"translate_title":"在卖空者批评和雷蒙德·詹姆斯为其人工智能故事辩护后，RadNet(RDNT)的估值检查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AI":0.71,"RJF":1.5,"RDNT":1.5},"content_text":"RadNet (RDNT) has been on a rollercoaster after Hunterbrook Capital’s short report hammered the stock, only for Raymond James to step in and defend the company, remaining positive on its long term outlook. See our latest analysis for RadNet. Against that backdrop, RadNet’s share price has whipsawed but is still up solidly on a year to date basis. Its exceptional three year total shareholder return suggests the long term momentum story is intact despite near term volatility. If this kind of tug of war between growth expectations and risk is on your radar, it may be worth scanning comparable healthcare names through healthcare stocks. With shares still up this year, a three year return above 300 percent, and Wall Street targets sitting almost 20 percent higher than today’s price, is RadNet now a mispriced opportunity, or is future growth already fully baked in? Most Popular Narrative Narrative: 16.4% Undervalued With RadNet last closing at $76.68 against a narrative fair value near $92.50, the story assumes meaningful upside from today’s levels.  Ongoing investments in AI powered imaging solutions (e.g., DeepHealth, See Mode, iCAD) are materially increasing center throughput, boosting capacity utilization, and driving more high margin advanced procedures, directly enhancing both revenue growth and EBITDA margins as adoption scales through 2026.  Read the complete narrative. Curious how a business that is still loss making today gets credit for future profitability, richer margins, and a premium earnings multiple usually reserved for market darlings? The narrative leans on ambitious revenue compounding, sharply higher margins, and a punchy future valuation multiple to bridge that gap. Want to see the exact growth and profit roadmap behind that price? Result: Fair Value of $92.50 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, significant upfront AI and digital health spending, along with reimbursement or volume setbacks, could quickly squeeze margins and challenge those upbeat long term assumptions. Find out about the key risks to this RadNet narrative. Another View: Market Ratios Tell A Richer Story While the AI driven narrative suggests upside, the market’s own numbers are cooler. RadNet trades on a price to sales ratio of 3 times, far richer than the US Healthcare industry at 1.3 times, peers at 1.1 times, and a fair ratio of just 0.9 times. If sentiment turns, could that premium unwind faster than the growth materializes? See what the numbers say about this price — find out in our valuation breakdown. NasdaqGM:RDNT PS Ratio as at Dec 2025 Build Your Own RadNet Narrative If you are not fully aligned with this view, or enjoy digging into the numbers yourself, you can build a custom narrative in just minutes, Do it your way. A great starting point for your RadNet research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision. Looking for more investment ideas? RadNet might be compelling, but do not stop there. Use the Simply Wall Street Screener now to uncover your next edge before everyone else catches on.  Capture momentum early by following these 25 AI penny stocks as innovation in machine learning and automation reshapes entire industries and creates fresh growth leaders. Identify potential value by scanning these 914 undervalued stocks based on cash flows where strong cash flows and sensible prices can tilt the odds in your favor. Strengthen your income stream with these 13 dividend stocks with yields > 3% and pinpoint companies offering attractive yields supported by solid fundamentals.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Mobile Infrastructure for Defense and DisasterThe next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.Get the investor briefing before the next round of contractsSponsored On Behalf of CiTechNew: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592373111","isCrawlerRequest":true}